Enovis CORP (ENOV) — SEC Financial Statements & Analysis

Enovis CORP (ENOV) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. Enovis CORP trades on NYSE as: ENOV. Enovis CORP (ENOV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Enovis CORP carries a market cap of $1.19B, a P/E ratio of -1.08x, a P/B ratio of 0.81x, a P/S ratio of 0.52x, an enterprise value of $2.46B, and an EV/EBITDA multiple of -3.19x. On profitability, it posts a gross margin of 61.09%, an operating margin of -45.14%, a net margin of -47.96%, a Return on Equity (ROE) of -54.26%, a Return on Assets (ROA) of -25.07%, and a Return on Invested Capital (ROIC) of -30.77%. Per share, it reports EPS of $-19.12, diluted EPS of $-19.12, free cash flow per share of $1.11, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 4.89% year-over-year, net income growth of 33.23% year-over-year, and EPS growth of 32.14% year-over-year. On the balance sheet, it maintains a current ratio of 1.98x, a quick ratio of 0.92x, working capital of $602.64M, a debt-to-equity ratio of 1.55x, a debt ratio of 0.61, an interest coverage ratio of -30.90x, free cash flow of $63.66M (TTM), and net debt of $1.27B. Figures sourced from SEC EDGAR.

Market Cap

$1.19B

P/E TTM

-1.08x

EPS TTM

$-19.12

P/B TTM

0.81x

ROE TTM

-54.26%

ROA TTM

-25.07%

Debt To Equity

1.55x

Free Cash Flow TTM

$63.66M

Net Revenue TTM Growth 1Y

4.89%

Data as of 2026-06-30 · Source: SEC EDGAR